INA-RESPOND (Indonesia Research Partnership on Infectious Diseases) is a
research partnership between the Government of Indonesia and the Government
of the United States aimed at strengthening clinical research capacity and
generating high-quality scientific evidence to address infectious diseases.
Through its research network involving hospitals, laboratories, and research
institutions across Indonesia, INA-RESPOND serves as a collaborative platform
that connects national and international researchers to conduct health research
that meets international scientific and ethical standards.
In response to the increasing challenges posed by infectious diseases and global
health threats, INA-RESPOND continues to strengthen national clinical research
systems through the development of research networks, enhancement of reference
laboratory capacity, research data management, and human resource
development in clinical research.
INA-RESPOND
Brief History
INA-RESPOND was initiated in 2010 and officially established in 2011 as a bilateral partnership between the Governments of Indonesia and the United States in infectious disease research.
The first INA-RESPOND multicenter study, Acute Febrile Illness Research in Indonesia (AFIRE) (2013–2016), marked a key milestone in the development of the network. The study produced scientific findings that contributed to national health policy and strengthened laboratory and research systems to support responses to infectious disease outbreaks.
Since then, INA-RESPOND has developed into a multicenter clinical research network capable of conducting observational studies and international clinical trials while producing scientific publications in internationally recognized journals.